Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
3004 articles
Articles
Psychiatrist Jonathan M. Raines Earns 12th Consecutive Castle Connolly Top Doctor Recognition
Renowned psychiatrist Jonathan M. Raines, MD, has once again been honored as a Castle Connolly Top Doctor for 2024, marking his 12th year receiving this distinguished recognition. This accolade, bestowed upon only about 7 percent of licensed physicians in their respective specialties, underscores Dr. Raines' continued excel...
November 19, 2024Read the full article
Fintech Veteran Eric Hannelius Donates to The Superhumans Center, Highlighting Cross-Industry Support for Advanced Orthopedic Care
Eric Hannelius, a veteran in the fintech industry, has expanded his philanthropic reach into the healthcare sector with a significant donation to The Superhumans Center, an innovative orthopedic clinic specializing in the treatment and rehabilitation of war victims. This generous contribution underscores the growing importa...
November 19, 2024Read the full article
Impact BioMedical Inc. Advances Chronic Disease Solutions with Patented Technologies
Impact BioMedical Inc. (NYSEAmerican: IBO) is establishing itself as a significant player in addressing chronic diseases, which the World Health Organization identifies as the leading global health threat. The company, which completed its initial public offering in September 2024 raising $4.5 million, leverages innovative t...
November 18, 2024Read the full article
Alpha Diet Supplement Gains Popularity as Non-Invasive Weight Management Solution
The Alpha Diet, a weight management supplement developed by health and wellness company WRZ, is gaining significant attention across the United States for its stress-free approach to weight control. This solution has attracted models, celebrities, and influencers seeking practical wellness options that integrate easily into...
November 18, 2024Read the full article
Alpha Diet Gains Popularity as Effortless Weight Management Solution
The Alpha Diet, a new weight management solution developed by health company WRZ, is gaining significant attention in the United States health and wellness industry, particularly among celebrities, models, and influencers. This supplement combines alpha-cyclodextrin, indigestible maltodextrin, and cauliflower mushroom to cr...
November 18, 2024Read the full article
Reconditioned Pacemakers Show Comparable Performance to New Devices in International Trial
The 'My Heart Your Heart' (MHYH) study, led by Dr. Thomas Crawford from the University of Michigan Medical School, compared the function and safety of refurbished pacemakers to new devices over a 90-day period following implantation. This research, presented at the American Heart Association's Scientific Sessions 2024 in Ch...
November 17, 2024Read the full article
Electronic Reminders with Cardiovascular Messaging Boost Flu Vaccination Rates Among Heart Attack Survivors
A series of clinical trials in Denmark has demonstrated the effectiveness of electronic reminders in increasing influenza vaccination rates, with particularly strong results among heart attack survivors. The research, presented at the American Heart Association's Scientific Sessions 2024 and published in JAMA Cardiology, of...
November 17, 2024Read the full article
Study Finds Combination Blood Pressure Pills Equally Effective in Indian Population
A study conducted in India has revealed that combination pills containing two different blood pressure medications are equally effective in lowering blood pressure among adults. The findings, presented at the American Heart Association's Scientific Sessions 2024 in Chicago, could have significant implications for the treatm...
November 17, 2024Read the full article
Clinical Trial Shows Spironolactone Reduces Heart Failure Risk After Heart Attack
The CLEAR SYNERGY trial presented at the American Heart Association's Scientific Sessions 2024 and published in the New England Journal of Medicine demonstrates that spironolactone significantly reduces heart failure risk in heart attack survivors. This randomized, double-blind, placebo-controlled study involving over 7,000...
November 17, 2024Read the full article
Study Finds Edoxaban Effective Alternative to Warfarin for Heart Valve Patients
The ENBALV trial, conducted in Japan and presented at the American Heart Association's Scientific Sessions 2024, compared edoxaban to warfarin in approximately 400 adults who had undergone bioprosthetic heart valve replacement surgery. The study found that only 0.5% of patients receiving edoxaban experienced a stroke or sys...
November 17, 2024Read the full article
GLORIOUS Trial Finds No Significant Benefit for Exenatide in Heart Surgery Patients
The GLORIOUS trial, presented at the American Heart Association's Scientific Sessions 2024 in Chicago, found that using exenatide during heart surgeries involving cardiopulmonary bypass did not provide significant benefits in reducing complications or mortality rates. The study involved approximately 1,400 adult patients un...
November 17, 2024Read the full article
New AI Program PanEcho Shows High Accuracy in Comprehensive Echocardiogram Analysis
Researchers have developed a new artificial intelligence program that could revolutionize echocardiogram analysis, potentially leading to faster diagnoses and more timely medical interventions. The program, named PanEcho, was presented at the American Heart Association's Scientific Sessions 2024 in Chicago as part of late-b...
November 16, 2024Read the full article
Pharmacist Feedback Program Improves Heart Failure Care for Veterans
A study presented at the American Heart Association's Scientific Sessions 2024 shows that providing feedback to pharmacists significantly improves care for veterans with heart failure. The research conducted within the Veterans Health Administration System found that pharmacists who received feedback on their patients' hear...
November 16, 2024Read the full article
Study Finds Anti-Clotting Drugs Ineffective for Cognitive Protection in Younger AFib Patients
The Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF), presented at the American Heart Association's Scientific Sessions 2024, found that anti-clotting medications do not reduce the risk of cognitive decline, stroke, or transient ischemic a...
November 16, 2024Read the full article
Study Suggests Ablation as First-Line Treatment for Heart Attack Survivors with Ventricular Tachycardia
The VANISH2 trial, led by Dr. John Sapp of Dalhousie University and simultaneously published in The New England Journal of Medicine, enrolled 416 patients across 22 health centers in three countries. All participants had survived a heart attack and subsequently developed recurrent ventricular tachycardia, putting them at ri...
November 16, 2024Read the full article
Intensive Blood Pressure Control Reduces Cardiovascular Risk in Type 2 Diabetes Patients
The Blood Pressure Control Target in Diabetes (BPROAD) Study presented at the American Heart Association's Scientific Sessions 2024 reveals that intensive systolic blood pressure management significantly reduces cardiovascular risks for individuals with Type 2 diabetes. Conducted across 145 sites in China with nearly 13,000...
November 16, 2024Read the full article
REMSleep Delays Deltawave Sleep Apnea Mask Launch to January 2025 Due to Regulatory and Supply Chain Requirements
REMSleep Holdings, Inc. has announced a delay in the launch of its anticipated Deltawave product, with the nasal pillows mask now projected to be available to consumers by the end of January 2025. This represents a setback from previous timelines. The company attributes the delay primarily to the need to ensure full complia...
November 15, 2024Read the full article
Connecta and Viasat Partnership to Transform Remote Connectivity Through ELEVATE Marketplace
The satellite communications industry is witnessing a transformative development as Connecta announces a strategic partnership with global communications company Viasat, centered around the Viasat ELEVATE marketplace. This collaboration aims to revolutionize IoT and satellite connectivity access in some of the world's most ...
November 15, 2024Read the full article
Physical Therapist's Book Offers Seniors Strategies to Maintain Independence and Avoid Nursing Home Care
Dr. Loraine Lovejoy-Evans, a physical therapist with over three decades of experience, has released a book titled 'No Nursing Home For Me!' that provides clear steps for older adults to manage pain, enhance mobility, and improve overall well-being while remaining in their own homes. The guide's practical approach addresses ...
November 15, 2024Read the full article
Acadia Healthcare Faces Expanded Securities Lawsuit Following VA Investigation Reports
Acadia Healthcare Company now faces an expanded securities class action lawsuit with the class period extended to October 18, 2024, following a New York Times report revealing that the Veterans Affairs Department has launched an investigation into the company's practices. The lawsuit, initially filed on October 29, 2024, al...
November 14, 2024Read the full article
Play Pixo Launches AI-Driven EdTech Platform Integrating Vedic Mathematics
Play Pixo has officially launched its advanced educational technology platform, representing a significant development in how children and young adults engage with digital learning. Incubated at the prestigious Indian Institute of Technology (IIT) Madras, this platform addresses growing concerns about maintaining children's...
November 14, 2024Read the full article